News

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade

13.09.2013 - Bionor Pharma ASA (OSE: BIONOR) announces that members of the Company's Board of Directors and Management participated in the Company's Private Placement and purchased a total of 215,908 shares of NOK 2.75 per share.

  * Deputy Chairman Øystein Soug purchased 54,545 shares and controls after the
    transaction a total of 79,545 shares in the Company
  * Director Benedicte Fossum purchased 36,363 shares through her Company Mittas
    AS and controls after the transaction a total of 36,363 shares in the
    Company
  * CEO Anker Lundemose purchased 100,000 shares and controls after the
    transaction a total of 100,000 shares in the Company
  * CFO Synne H. Røine purchased 25,000 shares and controls after the
    transaction a total of 25,000 shares in the Company

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act).

Bionor Pharma ASA

Synne H Røine
CFO

Tel +47 99 22 98 92